Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
88.26
+0.42 (0.47%)
Jan 23, 2025, 10:14 AM EST - Market open
Medtronic Revenue
Medtronic had revenue of $8.40B in the quarter ending October 25, 2024, with 5.25% growth. This brings the company's revenue in the last twelve months to $33.00B, up 3.25% year-over-year. In the fiscal year ending April 26, 2024, Medtronic had annual revenue of $32.36B with 3.64% growth.
Revenue (ttm)
$33.00B
Revenue Growth
+3.25%
P/S Ratio
3.48
Revenue / Employee
$347,326
Employees
95,000
Market Cap
113.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
Apr 26, 2019 | Pro | Pro | Pro |
Apr 27, 2018 | Pro | Pro | Pro |
Apr 28, 2017 | Pro | Pro | Pro |
Apr 29, 2016 | Pro | Pro | Pro |
Apr 24, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
MDT News
- 2 days ago - Medtronic appoints Renault's exec Thierry Piéton as finance chief - Reuters
- 2 days ago - Medtronic appoints Thierry Piéton as Chief Financial Officer - PRNewsWire
- 9 days ago - Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) - Seeking Alpha
- 9 days ago - Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System - PRNewsWire
- 10 days ago - Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology - PRNewsWire
- 15 days ago - Medtronic: Scoop Up This Dividend Aristocrat On Sale Now - Seeking Alpha
- 16 days ago - Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division - Accesswire
- 16 days ago - Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - PRNewsWire